Calpain-mediated proteolysis of polycystin-1 C-terminus induces JAK2 and ERK signal alterationsopen access
- Authors
- Kim, Hyunho; Kang, Ah-Young; Ko, Ah-ra; Park, Hayne Cho; So, Insuk; Park, Jong Hoon; Cheong, Hae Il; Hwang, Young-Hwan; Ahn, Curie
- Issue Date
- Jan-2014
- Publisher
- ELSEVIER INC
- Keywords
- Polycystic kidney disease; Polycystin-1; Calpain; PEST; Calcium homeostasis
- Citation
- EXPERIMENTAL CELL RESEARCH, v.320, no.1, pp 62 - 68
- Pages
- 7
- Journal Title
- EXPERIMENTAL CELL RESEARCH
- Volume
- 320
- Number
- 1
- Start Page
- 62
- End Page
- 68
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/11020
- DOI
- 10.1016/j.yexcr.2013.10.012
- ISSN
- 0014-4827
1090-2422
- Abstract
- Autosomal dominant polycystic kidney disease (ADPKD), a hereditary renal disease caused by mutations in PKD1 (85%) or PKD2 (15%), is characterized by the development of gradually enlarging multiple renal cysts and progressive renal failure. Polycystin-1 (PC1), PKD1 gene product, is an integral membrane glycoprotein which regulates a number of different biological processes including cell proliferation, apoptosis, cell polarity, and tubulogenesis. PC1 is a target of various proteolytic cleavages and proteosomal degradations, but its role in intracellular signaling pathways remains poorly understood. Herein, we demonstrated that PC1 is a novel substrate for mu- and m-calpains, which are calcium-dependent cysteine proteases. Overexpression of PC1 altered both Janus-activated kinase 2 (JAK2) and extracellular signal-regulated kinase (ERK) signals, which were independently regulated by calpain-mediated PC1 degradation. They suggest that the PC1 function on JAK2 and ERK signaling pathways might be regulated by calpains in response to the changes in intracellular calcium concentration. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - 이과대학 > 생명시스템학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.